HURA today
$1.44-$0.08 (-5.26%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourLeaning Bullish
1 hourStrong Bearish
15 minExpanding
5 minStrong Bearish
Daily trend turns down below $1.27
Key levels
Resistance$1.85
Resistance$1.55
Support$1.27
Support$1.02
Latest news & SEC filings
NewsTuHURA Biosciences draws $1.5 million more from credit facility
SEC FilingTuHURA Biosciences, Inc. filed a report on a major company event (Form 8-K)
AnalystHC Wainwright Repeats Buy Rating on TuHURA Biosciences, $10 Target
All HURA news →About TuHURA Biosciences
TuHURA Biosciences is a clinical-stage immuno-oncology company developing therapies intended to overcome resistance to cancer immunotherapies. Its lead candidate, IFx-2.0, is an innate immune agonist being tested as an adjunct to pembrolizumab in advanced Merkel cell carcinoma. The company also develops TBS-2025, a VISTA-inhibiting antibody for acute myeloid leukemia, and Delta Opioid Receptor-targeted antibody-drug conjugates. It operates in the United States.
Based on the company's 10-K filed Mar 31, 2026.
Nasdaq · Healthcare
TuHURA Biosciences, Inc./NV (HURA)
What Is the Price Target for HURA?
SEPT Low Target
$9.00
SEPT Mid Target
$9.50
SEPT High Target
$10.00
Analyst Consensus
$9.50
Is HURA a Buy or Sell Right Now?
Thesis
- •SEC filings signal active product innovation — 5 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for HURA.
Start Free Trial →Is HURA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$7.31
10
Moat Score
NONE
2/9
Piotroski Score
0.1
Altman Z-Score
What Is Smart Money Doing with HURA?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Bianco James A. | director officer | Sale | 150,000 | - | May 28, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →HURA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for HURA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for HURA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:06:15 | $1.46 | 6,718 | $$10K | BUY |
| 16:02:46 | $1.45 | 1,600 | $$2K | BUY |
| 16:02:46 | $1.45 | 1,900 | $$3K | BUY |
| 16:02:32 | $1.44 | 3,993 | $$6K | BUY |
| 16:02:32 | $1.44 | 4,200 | $$6K | BUY |
5 dark pool trades shown · $$27K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for TuHURA Biosciences, Inc./NV (HURA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →HURA — frequently asked questions
What is HURA stock price today?
TuHURA Biosciences, Inc./NV (HURA) is at $1.44, down 5.26% (-$0.08) at the Nov 12, 2026 close.
Why is HURA stock moving today?
Latest HURA news — Nov 7, 2026: TuHURA Biosciences draws $1.5 million more from credit facility · Nov 6, 2026: TuHURA Biosciences, Inc. filed a report on a major company event (Form 8-K)
What is the HURA price target?
The average analyst price target for HURA is $9.50, ranging from $9 to $10, based on 2 analysts.
What do analysts rate HURA?
Analyst ratings for HURA: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did HURA beat earnings?
HURA last reported on Aug 14, 2026: EPS -$0.14 vs -$0.15 expected — a beat of 8.7%.
Does HURA pay a dividend?
HURA does not currently pay a dividend.
How much debt does HURA have?
TuHURA Biosciences, Inc./NV reported $4M of debt and $1M of cash (Jun 30, 2026).
What are HURA support and resistance levels?
Support: $1.27, $1.02, $0.78. Resistance: $1.55, $1.85, $2.03.
What are insiders doing with HURA?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on HURA?
Nov 7, 2026: TuHURA Biosciences draws $1.5 million more from credit facility · Nov 6, 2026: TuHURA Biosciences, Inc. filed a report on a major company event (Form 8-K) · Oct 27, 2026: HC Wainwright Repeats Buy Rating on TuHURA Biosciences, $10 Target